c-Myc Signalling in the Genetic Mechanism of Polycystic Kidney Disease
Main Article Content
ABSTRACT
The Myc family of transcription factors regulates major biological processes such as proliferation, stem/progenitor cell pluripotency, metabolism, apoptosis, cell growth and differentiation. The most-studied member c-Myc is essential in embryonic development and cellular homeostasis. Dysregulation of c-Myc protein function is not only associated with malignant transformation and human tumors but is also implicated in autosomal dominant polycystic kidney disease (ADPKD), a human genetic disorder, considered a neoplasia in disguise. Studies from human ADPKD kidneys, caused by mutation in the PKD1 or PKD2 genes, revealed high expression of c-Myc with strong signal detected over cystic tubular epithelium. Consistent with human ADPKD pathogenesis, mouse models produced by dysregulation of Pkd1 and Pkd2 gene dosage show stimulation of renal c-Myc expression. Induced renal c-Myc expression is also observed in several non-orthologous animal models of PKD. Significantly, c-Myc overexpression specifically targeted to renal epithelial cells in transgenic mice closely reproduces human ADPKD. The specific causal effect of c-Myc in PKD was demonstrated by targeting different oncogenes which could not mimic the PKD phenotype. In fact, c-Myc was shown to be a major mediator of renal cystogenesis through various mechanisms and signalling pathways. Most importantly, inhibition of c-Myc in vivo, directly by repressing translation or indirectly with a small-molecule inhibitor, significantly delayed cystogenesis in the mouse. In summary, c-Myc is a central node in the pathogenesis of Pkd1/Pkd2 mouse models and of human ADPKD development and progression.
Downloads
Metrics
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of individual chapters belongs to the respective authors. The authors grant unrestricted publishing and distribution rights to the publisher. The electronic versions of the chapters are published under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Users are allowed to share and adapt the chapters for any non-commercial purposes as long as the authors and the publisher are explicitly identified and properly acknowledged as the original source. The books in their entirety are subject to copyright by the publisher. The reproduction, modification, republication and display of the books in their entirety, in any form, by anyone, for commercial purposes are strictly prohibited without the written consent of the publisher.